Literature DB >> 12511523

Angiotensinogen gene haplotype and hypertension: interaction with ACE gene I allele.

Chia-Ti Tsai1, Daniele Fallin, Fu-Tien Chiang, Juey-Jen Hwang, Ling-Ping Lai, Kuan-Lih Hsu, Chuen-Den Tseng, Chiau-Suong Liau, Yung-Zu Tseng.   

Abstract

There are many reports demonstrating the association of renin-angiotensin system gene polymorphisms with hypertension in different populations. In the present study, we used haplotype analyses of the angiotensinogen gene with a new permutation-based hypothesis testing method to determine the association between multilocus angiotensinogen gene polymorphisms and hypertension in a relatively homogeneous Taiwanese population. We also genotyped angiotensin-converting enzyme gene insertion/deletion polymorphism and angiotensin II type 1-receptor gene A1166C polymorphism to detect epistatic gene-gene interactions. There were 408 patients with hypertension (hypertensives) and 286 controls. The angiotensinogen gene haplotype frequencies were significantly different between hypertensives and controls, and this finding was only present in subjects with angiotensin-converting enzyme gene II genotypes when the analysis was stratified by genotype of this polymorphism. In addition, the angiotensinogen gene haplotype structure of hypertensives was more heterogeneous than that of controls. Our results showed that angiotensinogen gene haplotypes were associated with hypertension and might act synergistically with I allele of the angiotensin-converting enzyme gene.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12511523     DOI: 10.1161/01.hyp.0000045080.28739.12

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  25 in total

Review 1.  Between candidate genes and whole genomes: time for alternative approaches in blood pressure genetics.

Authors:  Jacob Basson; Jeannette Simino; D C Rao
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

2.  Incorporating genotyping uncertainty in haplotype inference for single-nucleotide polymorphisms.

Authors:  Hosung Kang; Zhaohui S Qin; Tianhua Niu; Jun S Liu
Journal:  Am J Hum Genet       Date:  2004-02-13       Impact factor: 11.025

3.  Gene-gene interaction between tuberculosis candidate genes in a South African population.

Authors:  Erika de Wit; Lize van der Merwe; Paul D van Helden; Eileen G Hoal
Journal:  Mamm Genome       Date:  2010-08-27       Impact factor: 2.957

4.  Particle swarm optimization algorithm for analyzing SNP-SNP interaction of renin-angiotensin system genes against hypertension.

Authors:  Shyh-Jong Wu; Li-Yeh Chuang; Yu-Da Lin; Wen-Hsien Ho; Fu-Tien Chiang; Cheng-Hong Yang; Hsueh-Wei Chang
Journal:  Mol Biol Rep       Date:  2013-05-22       Impact factor: 2.316

5.  Associations between RAS Gene polymorphisms, environmental factors and hypertension in Mongolian people.

Authors:  Wang Gui-yan; Wang Yan-hua; Xu Qun; Tong Wei-jun; Gu Ming-ling; Wang Jian; Fang Ming-wu; Zhang Yong-hong
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

6.  Single nucleotide polymorphism-single nucleotide polymorphism interactions among inflammation genes in the genetic architecture of blood pressure in the Framingham Heart Study.

Authors:  Jacob J Basson; Lisa de Las Fuentes; Dabeeru C Rao
Journal:  Am J Hypertens       Date:  2014-07-25       Impact factor: 2.689

7.  Gene-education interactions identify novel blood pressure loci in the Framingham Heart Study.

Authors:  Jacob Basson; Yun Ju Sung; Karen Schwander; Rezart Kume; Jeannette Simino; Lisa de las Fuentes; Dabeeru Rao
Journal:  Am J Hypertens       Date:  2014-01-28       Impact factor: 2.689

8.  Impact of interactions between risk alleles on clinical endpoints in hypertension.

Authors:  Samantha Kohli; Rahul Kumar; Mohit Gupta; Sanjay Tyagi; M A Qadar Pasha
Journal:  Heart Asia       Date:  2016-05-19

9.  Association of angiotensinogen haplotypes with angiotensinogen levels but not with blood pressure or coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study.

Authors:  Wilfried Renner; Markus Nauck; Bernhard R Winkelmann; Michael M Hoffmann; Hubert Scharnagl; Volker Mayer; Bernhard O Boehm; Winfried März
Journal:  J Mol Med (Berl)       Date:  2004-12-15       Impact factor: 4.599

10.  Role of pharmacogenomics in drug discovery and development.

Authors:  A Surendiran; S C Pradhan; C Adithan
Journal:  Indian J Pharmacol       Date:  2008-08       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.